Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion criteria:~1. healthy male subjects~Exclusion criteria:~1. Any relevant deviation from healthy conditions

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 1 BI 113608 (Type: ACTIVE_COMPARATOR): powder in the bottle for oral solution, oral administration with 240 mL water
- 2 BI 113608 (Type: EXPERIMENTAL): conventional tablet formulation
- 3 BI 113608 (Type: EXPERIMENTAL): conventional tablet formulation, fed
- 4 BI 113608 (Type: EXPERIMENTAL): conventional tablet after pantoprazole administration
- 5 BI 113608 (Type: EXPERIMENTAL): conventional tablet formulation, fasted, 0:30 min before fat breakfast

Based on this trial design, predict the completion outcome and termination type (if applicable).